Home LiteratureArticle Details
PMID: 15326224 Published · epublish English Journal Article Research Support, U.S. Gov't, P.H.S.

The effect of eukaryotic release factor depletion on translation termination in human cell lines.

Nucleic acids research ·Vol. 32 ·No. 15 ·2004-00-00 ·Pages 4491-502

Janzen DM, Geballe AP

Abstract

Two competing events, termination and readthrough (or nonsense suppression), can occur when a stop codon reaches the A-site of a translating ribosome. Translation termination results in hydrolysis of the final peptidyl-tRNA bond and release of the completed nascent polypeptide. Alternatively, readthrough, in which the stop codon is erroneously decoded by a suppressor or near cognate transfer RNA (tRNA), results in translation past the stop codon and production of a protein with a C-terminal extension. The relative frequency of termination versus readthrough is determined by parameters such as the stop codon nucleotide context, the activities of termination factors and the abundance of suppressor tRNAs. Using a sensitive and versatile readthrough assay in conjunction with RNA interference technology, we assessed the effects of depleting eukaryotic releases factors 1 and 3 (eRF1 and eRF3) on the termination reaction in human cell lines. Consistent with the established role of eRF1 in triggering peptidyl-tRNA hydrolysis, we found that depletion of eRF1 enhances readthrough at all three stop codons in 293 cells and HeLa cells. The role of eRF3 in eukarytotic translation termination is less well understood as its overexpression has been shown to have anti-suppressor effects in yeast but not mammalian systems. We found that depletion of eRF3 has little or no effect on readthrough in 293 cells but does increase readthrough at all three stop codons in HeLa cells. These results support a direct role for eRF3 in translation termination in higher eukaryotes and also highlight the potential for differences in the abundance or activity of termination factors to modulate the balance of termination to readthrough reactions in a cell-type-specific manner.

MeSH Terms
Alkaline Phosphatase/analysis,genetics Cell Line Codon, Terminator HeLa Cells Humans Peptide Chain Termination, Translational Peptide Termination Factors/antagonists & inhibitors,genetics,physiology RNA Interference
Chemicals
Codon, Terminator ETF1 protein, human Peptide Termination Factors peptide-chain-release factor 3 Alkaline Phosphatase
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Janzen Deanna M
Division of Human Biology, Fred Hutchinson Cancer Research Center, PO Box 19024, 1100 Fairview Avenue North-C2-023, Seattle, WA 98109-1024, USA.
Geballe Adam P
References (46)
46 references, click to expand
  1. Eukaryotic release factors (eRFs) history.
    Biol Cell. 2003 May-Jun;95(3-4):195-209 PMID: 12867083
  2. Aminoglycoside antibiotics mediate context-dependent suppression of termination codons in a mammalian translation system.
    RNA. 2000 Jul;6(7):1044-55 PMID: 10917599
  3. A human homologue of the yeast GST1 gene codes for a GTP-binding protein and is expressed in a proliferation-dependent manner in mammalian cells.
    EMBO J. 1989 Dec 1;8(12):3807-14 PMID: 2511002
  4. Depletion of a Drosophila homolog of yeast Sup35p disrupts spindle assembly, chromosome segregation, and cytokinesis during male meiosis.
    Cell Motil Cytoskeleton. 1998;39(4):286-302 PMID: 9556329
  5. Overexpression of human release factor 1 alone has an antisuppressor effect in human cells.
    Mol Cell Biol. 1997 Jun;17(6):3164-72 PMID: 9154815
  6. Inhibition of translation termination mediated by an interaction of eukaryotic release factor 1 with a nascent peptidyl-tRNA.
    Mol Cell Biol. 2002 Dec;22(24):8562-70 PMID: 12446775
  7. The products of the SUP45 (eRF1) and SUP35 genes interact to mediate translation termination in Saccharomyces cerevisiae.
    EMBO J. 1995 Sep 1;14(17):4365-73 PMID: 7556078
  8. The eukaryotic polypeptide chain releasing factor (eRF3/GSPT) carrying the translation termination signal to the 3'-Poly(A) tail of mRNA. Direct association of erf3/GSPT with polyadenylate-binding protein.
    J Biol Chem. 1999 Jun 11;274(24):16677-80 PMID: 10358005
  9. Class-1 translation termination factors: invariant GGQ minidomain is essential for release activity and ribosome binding but not for stop codon recognition.
    Nucleic Acids Res. 2001 Oct 1;29(19):3982-7 PMID: 11574680
  10. Translational termination comes of age.
    Trends Biochem Sci. 2000 Nov;25(11):561-6 PMID: 11084369
  11. Werner syndrome protein limits MYC-induced cellular senescence.
    Genes Dev. 2003 Jul 1;17(13):1569-74 PMID: 12842909
  12. Formation and properties of S-protein complex with S-peptide-containing fusion protein.
    FEBS Lett. 1994 Feb 21;339(3):209-12 PMID: 8112457
  13. A highly conserved eukaryotic protein family possessing properties of polypeptide chain release factor.
    Nature. 1994 Dec 15;372(6507):701-3 PMID: 7990965
  14. Termination of translation in eukaryotes is governed by two interacting polypeptide chain release factors, eRF1 and eRF3.
    EMBO J. 1995 Aug 15;14(16):4065-72 PMID: 7664746
  15. Impact of the six nucleotides downstream of the stop codon on translation termination.
    EMBO Rep. 2001 Sep;2(9):787-93 PMID: 11520858
  16. Evasion of cellular antiviral responses by human cytomegalovirus TRS1 and IRS1.
    J Virol. 2004 Jan;78(1):197-205 PMID: 14671101
  17. Stop codon suppression via inhibition of eRF1 expression.
    RNA. 2003 Jun;9(6):648-53 PMID: 12756323
  18. The signal for a leaky UAG stop codon in several plant viruses includes the two downstream codons.
    J Mol Biol. 1991 Mar 20;218(2):365-73 PMID: 2010914
  19. Functional expression of eukaryotic polypeptide chain release factors 1 and 3 by means of baculovirus/insect cells and complex formation between the factors.
    Eur J Biochem. 1998 Aug 15;256(1):36-44 PMID: 9746343
  20. Suppressors in yeast.
    Curr Top Microbiol Immunol. 1974;64(0):1-47 PMID: 4602646
  21. The polypeptide chain release factor eRF1 specifically contacts the s(4)UGA stop codon located in the A site of eukaryotic ribosomes.
    Eur J Biochem. 2001 May;268(10):2896-904 PMID: 11358506
  22. Amber, ochre and opal suppressor tRNA genes derived from a human serine tRNA gene.
    EMBO J. 1985 Jan;4(1):213-21 PMID: 2990894
  23. Is there a human [psi]?
    C R Acad Sci III. 1996 Jun;319(6):487-92 PMID: 8881282
  24. Localization and characterization of the gene encoding release factor RF3 in Escherichia coli.
    Proc Natl Acad Sci U S A. 1994 Jun 21;91(13):5848-52 PMID: 8016077
  25. Eukaryotic polypeptide chain release factor eRF3 is an eRF1- and ribosome-dependent guanosine triphosphatase.
    RNA. 1996 Apr;2(4):334-41 PMID: 8634914
  26. Polypeptide chain termination in Saccharomyces cerevisiae.
    Curr Genet. 1994 May;25(5):385-95 PMID: 8082183
  27. Identification and characterization of mutations in the UPF1 gene that affect nonsense suppression and the formation of the Upf protein complex but not mRNA turnover.
    Mol Cell Biol. 1996 Oct;16(10):5491-506 PMID: 8816462
  28. A novel role of the mammalian GSPT/eRF3 associating with poly(A)-binding protein in Cap/Poly(A)-dependent translation.
    J Biol Chem. 2002 Dec 27;277(52):50286-92 PMID: 12381739
  29. A sensitive assay of translational fidelity (readthrough and termination) in eukaryotic cells.
    Biochemistry (Mosc). 1999 Dec;64(12):1408-17 PMID: 10648965
  30. Molecular cloning of a novel member of the eukaryotic polypeptide chain-releasing factors (eRF). Its identification as eRF3 interacting with eRF1.
    J Biol Chem. 1998 Aug 28;273(35):22254-9 PMID: 9712840
  31. Mutations in the highly conserved GGQ motif of class 1 polypeptide release factors abolish ability of human eRF1 to trigger peptidyl-tRNA hydrolysis.
    RNA. 1999 Aug;5(8):1014-20 PMID: 10445876
  32. Yeast polypeptide chain release factors eRF1 and eRF3 are involved in cytoskeleton organization and cell cycle regulation.
    Cell Motil Cytoskeleton. 2002 Jul;52(3):161-73 PMID: 12112144
  33. Sequence specificity of aminoglycoside-induced stop condon readthrough: potential implications for treatment of Duchenne muscular dystrophy.
    Ann Neurol. 2000 Aug;48(2):164-9 PMID: 10939566
  34. Clinically relevant aminoglycosides can suppress disease-associated premature stop mutations in the IDUA and P53 cDNAs in a mammalian translation system.
    J Mol Med (Berl). 2002 Jun;80(6):367-76 PMID: 12072912
  35. Gentamicin-mediated suppression of Hurler syndrome stop mutations restores a low level of alpha-L-iduronidase activity and reduces lysosomal glycosaminoglycan accumulation.
    Hum Mol Genet. 2001 Feb 1;10(3):291-9 PMID: 11159948
  36. [Identification of a novel termination release factor eRF3b expressing the eRF3 activity in vitro and in vivo].
    Mol Biol (Mosk). 2001 Jul-Aug;35(4):672-81 PMID: 11524954
  37. The invariant uridine of stop codons contacts the conserved NIKSR loop of human eRF1 in the ribosome.
    EMBO J. 2002 Oct 1;21(19):5302-11 PMID: 12356746
  38. UAG readthrough in mammalian cells: effect of upstream and downstream stop codon contexts reveal different signals.
    BMC Mol Biol. 2001;2:3 PMID: 11242562
  39. The surveillance complex interacts with the translation release factors to enhance termination and degrade aberrant mRNAs.
    Genes Dev. 1998 Jun 1;12(11):1665-77 PMID: 9620853
  40. Eukaryotic release factor 1 (eRF1) abolishes readthrough and competes with suppressor tRNAs at all three termination codons in messenger RNA.
    Nucleic Acids Res. 1997 Jun 15;25(12):2254-8 PMID: 9171074
  41. Conversion of omnipotent translation termination factor eRF1 into ciliate-like UGA-only unipotent eRF1.
    EMBO Rep. 2002 Sep;3(9):881-6 PMID: 12189178
  42. Mouse GSPT2, but not GSPT1, can substitute for yeast eRF3 in vivo.
    Genes Cells. 2002 Oct;7(10):1043-57 PMID: 12354098
  43. Mutations in eukaryotic release factors 1 and 3 act as general nonsense suppressors in Drosophila.
    Genetics. 2003 Oct;165(2):601-12 PMID: 14573473
  44. The role of Upf proteins in modulating the translation read-through of nonsense-containing transcripts.
    EMBO J. 2001 Feb 15;20(4):880-90 PMID: 11179232
  45. Omnipotent decoding potential resides in eukaryotic translation termination factor eRF1 of variant-code organisms and is modulated by the interactions of amino acid sequences within domain 1.
    Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):8494-9 PMID: 12084909
  46. Ribonuclease S-peptide as a carrier in fusion proteins.
    Protein Sci. 1993 Mar;2(3):348-56 PMID: 8453373
Article Info
Journal
Nucleic acids research
Abbr.
Nucleic Acids Res
ISSN
1362-4962
Published
2004-00-00
Epub
2004-00-23
Pages
4491-502
Language
English
Region
England
NLM ID
0411011
PMCID
PMC516063
Subset
IM
Grants
NCI NIH HHS · CA 09229 · United States
NCI NIH HHS · T32 CA009229 · United States
NIAID NIH HHS · R01 AI026672 · United States
NIAID NIH HHS · AI26672 · United States
NCI NIH HHS · CA91329 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com